[ Price : $8.95]
Federal Register notice: FDA announces the rates for prescription drug/biologic user fees for fiscal year 2024.[ Price : $8.95]
Three Democratic U.S. Senators introduce the Drug Shortages Prevention and Quality Improvement Act that would give FDA and CMS add...[ Price : $8.95]
FDA expands the medical device Total Product Life Cycle Advisory Program pilot to include the Office of Neurological and Physical ...[ Price : $8.95]
FDA sends Citius Pharmaceuticals a complete response letter on its BLA seeking approval for Lymphir (denileukin diftitox), indicat...[ Price : $8.95]
Abbott decides to stop selling its Trifecta heart valves due to the potential risk of early structural valve deterioration.[ Price : $8.95]
Federal Register notice: FDA requests comments on an information collection extension entitled Product Jurisdiction and Combinatio...[ Price : $8.95]
FDA posts a final guidance entitled Assessing User Fees Under the Biosimilar User Fee Amendments (BUSFA 3) of 2022.[ Price : $8.95]
GE HealthCare recalls its TruSignal SpO2 Sensors due to malfunction issues that may reduce defibrillation energy or expose patient...